Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia

Lipocalin 2 (LCN2) was recently identified as an endogenous ligand of the type 4 melanocortin receptor (MC4R), a critical regulator of appetite. However, it remains unknown if this molecule influences appetite during cancer cachexia, a devastating clinical entity characterized by decreased nutrition...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Brennan, Zhu, Xinxia, Norgard, Mason A., Levasseur, Peter R., Butler, John T., Buenafe, Abigail, Burfeind, Kevin G., Michaelis, Katherine A., Pelz, Katherine R., Mendez, Heike, Edwards, Jared, Krasnow, Stephanie M., Grossberg, Aaron J., Marks, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024334/
https://www.ncbi.nlm.nih.gov/pubmed/33824339
http://dx.doi.org/10.1038/s41467-021-22361-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024334/
https://www.ncbi.nlm.nih.gov/pubmed/33824339
http://dx.doi.org/10.1038/s41467-021-22361-3

Ejemplares similares